RNAssist Limited and QCMD Agree Collaboration for vivoPHIX™ Biomolecule Stabilization Technology

Cambridge and Glasgow, UK. 23rd January 2020 – RNAssist. (www.RNAssist.com) a UK company that has developed a universal biological sample stabilization, fixation and inactivation reagent for clinical diagnostic and research applications, and QCMD (www.qcmd.org) specialised in molecular infectious disease proficiency testing, announced today an agreement under which RNAssist will license its vivoPHIX™ technology to QCMD. QCMD… Poursuivre la lecture de RNAssist Limited and QCMD Agree Collaboration for vivoPHIX™ Biomolecule Stabilization Technology